Oramed Pharmaceuticals Inc. entered into a Securities Purchase Agreement with Scilex Holding Company, receiving a $101.875 million promissory note and warrants to purchase 17 million shares of Scilex's common stock, with specific payment terms and adjustments outlined for future payments.